Blood Salvage in Orthotopic Liver Transplantation With HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)
- Status
- RECRUITING
- Phase
- PHASE3
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures
- Status
- TERMINATED
- Phase
- NA
Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Lenvatinib Therapy in HCC Patients After LDLT
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Sitravatinib Plus Tislelizumab or Placebo Plus Tislelizumab Versus Placebo as Adjuvant Treatment in Participants With Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma
- Status
- RECRUITING
- Phase
- PHASE3
A Real World Study of Regogfinib in HCC
- Status
- UNKNOWN
- Phase
- N/A
TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection
- Status
- UNKNOWN
- Phase
- NA
Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence
- Status
- UNKNOWN
- Phase
- PHASE2
Predictive Model for Pain After TACE
- Status
- COMPLETED
- Phase
- N/A